Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04201873 |
|---|---|
| Brief Title: | Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma |
| First Submitted : | December 12, 2019 |
| First Submitted that Met QC Criteria : | December 13, 2019 |
| First Posted : | December 17, 2019 |
| Last Update Submitted that Met QC Criteria : | May 1, 2024 |
| Last Update Posted : | May 2, 2024 |